Prognostic Stage IIA Breast Cancer AJCC v8 Active Not Recruiting Phase 0 Trials for Durvalumab (DB11714)

Also known as: Prognostic Stage 2A Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Active Not Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs